Beranda › Sarkoma Ewing › Ohio
Uji klinis Sarkoma Ewing di Ohio
8 studi untuk Sarkoma Ewing mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 1
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07194044Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1
Usia 12 hingga 85 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT03715933Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05210374Single Arm Romiplostim to Prevent CIT
- Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase awal 1
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT07048249A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Menerima peserta
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 1/2
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 2
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.